glp 1 products Nature Made GLP-1 Companion Health Pack, 30 GLP-1 Boost+ | Natural GLP-1
Description
They enhance glucose-dependent insulin secretion from pancreatic beta cells, suppress inappropriate glucagon release from alpha cells, and slow gastric emptying
A detailed summary of study characteristics is presented in a data extraction table (Table 1)
The primary endpoint was the presence of increased RCG, defined as, the presence of solids, thick liquids, or more than 1.5 mL/kg of clear liquids on gastric ultrasonography. Among the 124 subjects (median age, 56 years, 60% female), the prevalence of increased RGC was 56% (35 of 62) in subjects with GLP-1 RA use compared with 19% (12 of 62) in subjects not taking a GLP-1 RA drug
Concerns arose from animal studies showing thyroid tumours in rodents, prompting regulatory warnings
Mounjaro (tirzepatide) Approved - A dual-action injectable targeting GLP-1 and GIP receptors
